Clinical trial
Evaluation and Optimization of the Technical and Clinical Performance of the…
NCT00247299 · Rambam Health Care Campus, Other · Unknown status
Key facts
| NCT number | NCT00247299 |
|---|---|
| Title | Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform |
| Official title | Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform |
| Lead sponsor | Rambam Health Care Campus, Other |
| Collaborators | Lumenis Be Ltd. Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Telangiectases, Port Wine Stain |
| Intervention type | Device |
| Interventions | IPL Quantum Product manufactured by Luminis Ltd. |
| Enrollment | 30 |
| Start date | May 1, 2005 |
| First posted | Nov 1, 2005 |
| Last update posted | Nov 1, 2005 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: